Cargando…

Molecular docking analysis of pyruvate kinase M2 with a potential inhibitor from the ZINC database

The pyruvate kinase M2 isoform (PKM2) is linked with cancer. Therefore, it is of interest to document the molecular docking analysis of Pyruvate Kinase M2 (PDB ID: 4G1N) with potential activators from the ZINC database. Thus, we document the optimal molecular docking features of a compound having ID...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Pankaj, Singh, Manvender, Sharma, Sangeeta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340708/ https://www.ncbi.nlm.nih.gov/pubmed/34393429 http://dx.doi.org/10.6026/97320630017139

Ejemplares similares

Molecular docking analysis of Clostridium perfringens beta toxin model with potential inhibitors from the ZINC database
por: Solanki, Amit Kumar, et al.
Publicado: (2021)

Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2020)

Molecular docking of potential inhibitors with the mTOR protein
por: Fathima, JH Shazia, et al.
Publicado: (2021)

Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis
por: Zhan, Cheng, et al.
Publicado: (2015)

Actinobase: Database on molecular diversity, phylogeny and biocatalytic potential of salt tolerant alkaliphilic actinomycetes
por: Sharma, Amit K, et al.
Publicado: (2012)

Molecular heterogeneity of pyruvate kinase deficiency
por: Bianchi, Paola, et al.
Publicado: (2020)

Pyruvate Kinase M2: A Potential Target for Regulating Inflammation
por: Alves-Filho, Jose C., et al.
Publicado: (2016)

Identification of Natural Compounds as Inhibitors of Pyruvate Kinase M2 for Cancer Treatment
por: Sarfraz, Iqra, et al.
Publicado: (2022)

Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening
por: Abdusalam, Ashraf Ahmed Ali, et al.
Publicado: (2020)

Protein kinase function of pyruvate kinase M2 and cancer
por: Chen, Xun, et al.
Publicado: (2020)

Comparative docking analysis of tyrosine kinase inhibitors with HER2 and HER4 receptors
por: Sonar, Priyanka, et al.
Publicado: (2022)

Molecular docking analysis of sphingosine kinase 1 inhibitors for cancer management
por: Barnawi, Jameel
Publicado: (2023)

Molecular docking analysis of COX-2 for potential inhibitors
por: Selvaraj, Jayaraman, et al.
Publicado: (2020)

Tumor pyruvate kinase M2: A promising molecular target of gastrointestinal cancer
por: Guo, Chen, et al.
Publicado: (2018)

Parkin Regulates the Activity of Pyruvate Kinase M2
por: Liu, Kun, et al.
Publicado: (2016)

Molecular docking of 1H-pyrazole derivatives to receptor tyrosine kinase and protein kinase for screening potential inhibitors
por: Chandra,, et al.
Publicado: (2014)

Identification of novel inhibitor targeting Fyn kinase using molecular docking analysis
por: Nedunchezhian, Dharani, et al.
Publicado: (2019)

Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts
por: Satyanarayana, Ganesh, et al.
Publicado: (2021)

Pyruvate Kinase M2 Expression, but Not Pyruvate Kinase Activity, Is Up-Regulated in a Grade-Specific Manner in Human Glioma
por: Mukherjee, Joydeep, et al.
Publicado: (2013)

Identification of Inhibitors against Metastasis Protein “Survivin:” In silico Discovery Using Virtual Screening and Molecular Docking Studies
por: Mishra, Swechha, et al.
Publicado: (2017)

Molecular Docking of Potential Inhibitors of Broccoli Myrosinase
por: Román, J., et al.
Publicado: (2018)

Role of isoenzyme M2 of pyruvate kinase in urothelial tumorigenesis
por: Zhou, Haiping, et al.
Publicado: (2016)

The role of pyruvate kinase M2 in anticancer therapeutic treatments
por: Su, Qiongli, et al.
Publicado: (2019)

Pyruvate kinase M2 deregulation enhances the metastatic potential of tongue squamous cell carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

Association of Phosphorylated Pyruvate Dehydrogenase with Pyruvate Kinase M2 Promotes PKM2 Stability in Response to Insulin
por: Hossain, Abu Jubayer, et al.
Publicado: (2023)

Comorbidities and complications in adults with pyruvate kinase deficiency
por: Boscoe, Audra N., et al.
Publicado: (2021)

Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis
por: Jain, Divya, et al.
Publicado: (2019)

A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome
por: Sharma, Ankita, et al.
Publicado: (2020)

Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments
por: Freitas de Freitas, Talita, et al.
Publicado: (2022)

Combined e-pharmacophore based screening and docking of PI3 kinase with potential inhibitors from a database of natural compounds
por: Eda, Sasidhar Reddy, et al.
Publicado: (2019)

In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2
por: Kalaiarasan, Ponnusamy, et al.
Publicado: (2015)

Pyruvate kinase isozyme M2 and glutaminase might be promising molecular targets for the treatment of gastric cancer
por: Kitayama, Kishu, et al.
Publicado: (2017)

Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases
por: Zhou, Xiaoli, et al.
Publicado: (2016)

Cryptosporidium parvum Pyruvate Kinase Inhibitors With in vivo Anti-cryptosporidial Efficacy
por: Khan, Shahbaz M., et al.
Publicado: (2022)

An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors
por: Xie, Huiding, et al.
Publicado: (2015)

Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
por: Anwar, Saleha, et al.
Publicado: (2020)

Pyruvate kinase M2 regulates photoreceptor structure, function, and viability
por: Rajala, Ammaji, et al.
Publicado: (2018)

Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer
por: Prakasam, Gopinath, et al.
Publicado: (2018)

An allostatic mechanism for M2 pyruvate kinase as an amino-acid sensor
por: Yuan, Meng, et al.
Publicado: (2018)

Redox regulation of pyruvate kinase M2 by cysteine oxidation and S-nitrosation
por: Mitchell, Alice Rose, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_evu8gfen51a0g0quja31l2112q